BiotechTube
Home/SynerFuse/Justin Zenanko, CPA, MDiv
JZ

Justin Zenanko, CPA, MDiv

Chief Executive Officer & Founder

SynerFuse

Therapeutic Areas

Chronic PainNeuroscience

SynerFuse Pipeline

DrugIndicationPhase
NeuroFuse System / e-TLIF ProcedureChronic low back and leg pain in patients undergoing lumbar spinal fusionFeasibility

Leadership Team at SynerFuse

NR
Nameer R. Haider, MD, FAAPM&R, DABPM
Chief Innovation Officer
RL
Rohan Lall, MD
Chief Medical Officer
MC
Michael C. Park, MD, PhD
Chief Technology Officer
View full SynerFuse profile